This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
August 08, 2018
Strongbridge Biopharma plc Reports Second Quarter 2018 Financial Results and Provides Corporate Update
August 08, 2018
Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2018 Results Presentation and Webcast
August 07, 2018
Altimmune to Announce Second Quarter 2018 Financial Results on August 15
August 02, 2018
BONESUPPORT Signs Agreement with MTF Biologics to Expand US Product Offering
July 26, 2018
BONESUPPORT HOLDING AB (publ) – Interim Report
July 26, 2018
CERENIS ANNOUNCES FINANCING FROM INVESTMENT FUNDS, MANAGEMENT, ITS BOARD OF DIRECTORS AND ITS ONCOLOGY SCIENTIFIC ADVISORY BOARD
July 26, 2018
GenSight Biologics Reports Interim Financial Results for the First Half of 2018
July 24, 2018
Q2 2018 Interim Report – invitation to conference call and webcast
July 24, 2018
Q2 2018 General Market Overview
July 18, 2018
BONESUPPORT appoints Michael Diefenbeck as Head of Research & Development, Medical and Clinical Affairs